Showing results (381-390 of 546) with videos related to

Sort By:
Pageof 55
Physical Chemistry Chemical Physics : PCCP|July 14, 2011
Synthesis of Ge-imogolite: influence of the hydrolysis ratio on the structure of the nanotubesC Levard, A Masion, J Rose, et al.
Diabetes Research and Clinical Practice|October 1, 1993
High viscosity hydroxypropylmethylcellulose reduces postprandial blood glucose concentrations in NIDDM patientsC Reppas, C H Adair, J L Barnett, et al.
Melanoma Research|September 9, 2011
Expression of CD133 and other putative stem cell markers in uveal melanomaMichelle Thill, Marc Jean Berna, Rebecca Grierson, et al.
Anticancer Research|July 23, 2011
The utility of an in vitro angiogenesis score for prognosis assessment in patients with cervical cancerSolveig Landt, Harald Heidecke, Cora Reuter, et al.
Journal of Materials Chemistry. B|April 8, 2020
Artificial cerium-based proenzymes confined in lyotropic liquid crystals: synthetic strategy and on-demand activationDenise R Bohn, Francielli O Lobato, Alisson S Thill, et al.
The Annals of Thoracic Surgery|October 18, 2021
Impact of Opioid-free Anesthesia After Video-assisted Thoracic Surgery: A Propensity Score StudyJean Selim, Xavier Jarlier, Thomas Clavier, et al.
BMJ Open|June 3, 2024
Opioid-free anaesthesia with dexmedetomidine and lidocaine versus remifentanil-based anaesthesia in cardiac surgery: study protocol of a French randomised, multicentre and single-blinded OFACS trialEmmanuel Besnier, Mouhamed Djahoum Moussa, Caroline Thill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival functionLeonid Gorelik, Anne H Cutler, Greg Thill, et al.
The Laryngoscope|May 22, 2020
Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux PatientsJerome R Lechien, Francois Bobin, Giovanni Dapri, et al.
Breast (Edinburgh, Scotland)|April 8, 2026
Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practiceHope S Rugo, Adam Brufsky, Rachel M Layman, et al.
Pageof 55